Skip to main content

Table

From: Impact of treatment modality, biochemical parameters and apoptosis on polymorphonuclear cell (PMN) function in patients with renal failure

  Controls CRF HD CAPD P *
Apoptosis, % 9.0 ± 5.6 19.8 ± 16.8 13.6 ± 9.3 6.4 ± 4.0 0.01
Phagocytosis, % 83.8 ± 7.5 79.2 ± 16.9 49.9 ± 28 86.4 ± 7.1 <0.0001
H2O2 release, MFI      
   SA-stimulated 357 ± 123.4 357.6 ± 30.6 90 ± 41.7 570.4 ± 41.5 0.012
   LPS-stimulated 44.6 ± 16.4 50.9 ± 30.0 48.5 ± 27.2 56.4 ± 33.1 0.77
   PMA-stimulated 110.6 ± 81.6 95.9 ± 93 37.7 ± 25 152.9 ± 79.6 0.023
   fMLP-stimulated 131.9 ± 75.7 72.9 ± 55.5 41.2 ± 16.4 189.2 ± 141.1 <0.001
  1. MFI, mean fluorescence intensity. *ANOVA; P < 0.05 versus controls and CAPD; P < 0.05 versus other groups.